Compare UNCY & HYMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNCY | HYMC |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.1M | 1.9B |
| IPO Year | 2021 | 2018 |
| Metric | UNCY | HYMC |
|---|---|---|
| Price | $4.77 | $21.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $25.67 | N/A |
| AVG Volume (30 Days) | 737.8K | ★ 1.8M |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 64.26 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $675,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $582.86 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.72 | $5.69 |
| 52 Week High | $8.74 | $58.73 |
| Indicator | UNCY | HYMC |
|---|---|---|
| Relative Strength Index (RSI) | 38.43 | 36.96 |
| Support Level | $3.93 | $18.77 |
| Resistance Level | $5.86 | $22.37 |
| Average True Range (ATR) | 0.22 | 1.41 |
| MACD | -0.04 | -0.45 |
| Stochastic Oscillator | 7.68 | 8.04 |
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
Hycroft Mining Holding Corp is a United States-based gold and silver exploration-stage issuer. The company owns and is focused on developing its property, the Hycroft Mine, located northwest of Winnemucca, Nevada.